Genovate Biotechnology Co., Ltd. (4130.TWO)
TWD 20.9
(-1.65%)
TWD 20.9
(-1.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 528.51 Million | 438.75 Million | 434.25 Million | 472.72 Million | 465.75 Million |
| Cost of Revenue | 317.59 Million | 283.88 Million | 284.5 Million | 279.61 Million | 269.47 Million |
| Gross Profit | 210.91 Million | 154.87 Million | 149.75 Million | 193.1 Million | 196.28 Million |
| Operating Expenses | 183.92 Million | 168.76 Million | 150.91 Million | 153.63 Million | 156.8 Million |
| Selling, General and Administrative Expenses | 110.29 Million | 106.88 Million | 95.49 Million | 98.7 Million | 99.95 Million |
| Research and Development Expenses | 73.61 Million | 61.87 Million | 55.42 Million | 54.93 Million | 56.84 Million |
| Other Expenses | -1.00 | 2.21 Million | 3.24 Million | 973 Thousand | - |
| Cost and Expenses | 501.5 Million | 452.65 Million | 435.41 Million | 433.25 Million | 426.27 Million |
| Operating Income | 27 Million | -8.72 Million | 3.82 Million | 40.97 Million | 39.47 Million |
| Interest Expense | 267 Thousand | 281 Thousand | 252 Thousand | 253 Thousand | 269 Thousand |
| Income Tax Expense | 1.49 Million | 3.32 Million | 3.19 Million | 2.02 Million | 6.61 Million |
| Earnings before Tax | 30.82 Million | -9 Million | 3.56 Million | 40.75 Million | 43.22 Million |
| Net Income | 29.33 Million | -12.32 Million | 372 Thousand | 38.73 Million | 34.05 Million |
| Earnings Per Share Basic | 0.27 | -0.11 | 0.00 | 0.36 | 0.30 |
| Earnings Per Share Diluted | 0.27 | -0.11 | 0.00 | 0.36 | 0.30 |
| Weighted Average Shares Outstanding | 109.37 Million | 107.89 Million | 107.87 Million | 107.87 Million | 112.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.5 Million | 107.89 Million | 107.92 Million | 108.07 Million | 112.83 Million |
| Gross Margin | 0.40 | 0.35 | 0.34 | 0.41 | 0.42 |
| EBIT Margin | 0.13 | 0.06 | 0.09 | 0.16 | 0.17 |
| Profit Margin | 0.06 | -0.03 | 0.00 | 0.08 | 0.07 |
| EBITDA | 67.64 Million | 27.36 Million | 39.63 Million | 76.18 Million | 77.61 Million |
| Earnings Before Tax Margin | 0.05 | -0.02 | 0.01 | 0.09 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 126.9 Million | 139.35 Million | 119.44 Million | 528.51 Million | 137.05 Million | 140.43 Million |
| Cost of Revenue | 76.67 Million | 83.26 Million | 76.14 Million | 317.59 Million | 82 Million | 79.38 Million |
| Gross Profit | 50.22 Million | 56.09 Million | 43.3 Million | 210.91 Million | 55.05 Million | 61.04 Million |
| Operating Expenses | 40.96 Million | 37.02 Million | 60.29 Million | 183.92 Million | 39.44 Million | 46.73 Million |
| Selling, General and Administrative Expenses | 26.8 Million | 25.12 Million | 31.06 Million | - | 28.56 Million | 26.38 Million |
| Research and Development Expenses | 14.16 Million | 11.89 Million | 29.23 Million | - | 10.88 Million | 20.35 Million |
| Other Expenses | 584 Thousand | 732 Thousand | 390 Thousand | 2.94 Million | 958 Thousand | 1.14 Million |
| Cost and Expenses | 117.64 Million | 120.28 Million | 136.44 Million | 501.51 Million | 121.44 Million | 126.12 Million |
| Operating Income | 10.8 Million | 20.9 Million | -17.17 Million | 31.07 Million | 17.13 Million | 16.2 Million |
| Interest Expense | 80 Thousand | 22 Thousand | 40 Thousand | 267 Thousand | 58 Thousand | 76 Thousand |
| Income Tax Expense | 2.73 Million | 4.23 Million | -2.89 Million | 1.49 Million | 93 Thousand | 2.54 Million |
| Earnings before Tax | 10.72 Million | 20.87 Million | -17.21 Million | 30.82 Million | 17.08 Million | 16.15 Million |
| Net Income | 7.99 Million | 16.63 Million | -14.32 Million | 29.33 Million | 16.99 Million | 13.6 Million |
| Earnings Per Share Basic | 0.07 | 0.15 | -0.13 | - | 0.16 | 0.12 |
| Earnings Per Share Diluted | 0.07 | 0.15 | -0.13 | - | 0.16 | 0.12 |
| Weighted Average Shares Outstanding | 114.15 Million | 110.92 Million | 110.14 Million | 109.37 Million | 106.18 Million | 113.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 114.15 Million | 110.92 Million | 110.21 Million | 109.5 Million | 106.18 Million | 113.4 Million |
| Gross Margin | 0.40 | 0.40 | 0.36 | 0.40 | 0.40 | 0.43 |
| EBIT Margin | 0.16 | 0.22 | -0.07 | - | 0.19 | 0.18 |
| Profit Margin | 0.06 | 0.12 | -0.12 | 0.06 | 0.12 | 0.10 |
| EBITDA | 20.15 Million | 30.02 Million | -7.93 Million | - | 26.36 Million | 25.27 Million |
| Earnings Before Tax Margin | 0.09 | 0.15 | -0.14 | 0.06 | 0.13 | 0.12 |
4147
DLHC
AMIGF
3217
7337
ZKIN